AzTrials
AzTrials

Total Hip ArthroplastyNCT01571492

Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative Analgesia

A study testing L2 Paravertebral catheter nerve block and Continuous Lumbar plexus nerve block in people with Total Hip Arthroplasty, run by University of Pittsburgh at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective study is intended to compare the analgesic efficacy, preservation of lower extremity motor power and side-effect profile of L2 Paravertebral lumbar plexus approach compared to Posterior nerve stimulation guided lumbar plexus approach, continuous local anesthetic infusion postoperative analgesia of… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Total Hip Arthroplasty
What is being tested?
L2 Paravertebral catheter nerve block and Continuous Lumbar plexus nerve block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
Jun 2009to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18-75 years
  • No contraindications to placement of a lumbar plexus posterior block or paravertebral block.
  • ASA status I-III
  • Scheduled for open total hip arthroplasty with the same surgeon.
  • Patients without painful conditions or chronic use of opioid or antineuropathic medications.
  • Patient who are not expected to receive therapeutic anticoagulation in the postoperative period.
  • No Known allergies to the medications used in the study.
  • Patients willing to receive spinal anesthesia

Who cannot join

  • Age under 18 years or older than 75 years.
  • Any contraindication to a placement of continuous lumbar plexus Block.
  • American Society of Anesthesiologist physical status IV or greater.
  • Chronic painful conditions.
  • Preoperative opioid tolerant use.
  • Coagulation Abnormalities or patients who are expected to be on therapeutic anticoagulants postoperatively.
Show all 15Show fewer
  • Allergy to any of the drugs/agents used study protocol.
  • Personal or family history of malignant hyperthermia.
  • Serum creatinine greater than 1.4 mg/dl.
  • Pregnancy
  • Having an altered mental status (not oriented to place, person, or time)
  • Any comorbid condition that, in the judgment of the consulting orthopedic surgeon, or intraoperative anesthesiologist, would proscribe the patient from any aspect of the study.
  • Patient refusal.
  • Lumbar plexus block performed with loss of resistance technique
  • Patient requiring postoperative management in the ICU

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UPMC Presbyterian Shadyside

    Pittsburgh, Pennsylvania, 15232

Other trials in United States

About this study

Official title: Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty

This prospective study is intended to compare the analgesic efficacy, preservation of lower extremity motor power and side-effect profile of L2 Paravertebral lumbar plexus approach compared to Posterior nerve stimulation guided lumbar plexus approach, continuous local anesthetic infusion postoperative analgesia of Total Hip Arthroplasty.

The L2 Paravertebral technique of lumbar plexus block, as part of a multimodal pain treatment, could be a cost-effective alternative with a equal profile of analgesic efficacy and motor power sparing with greater promotion of early achievement of postoperative physical therapy goals.

Read the detailed description

The nerve stimulator guided technique of continuous lumbar plexus block (LPB) is the accepted standard of care at University of Pittsburgh Medical Center (UPMC) for the management of postoperative analgesia after Total Hip Arthroplasty. Over 900 continuous lumbar plexus blocks were performed at UPMC Presbyterian Shadyside hospital within the last year alone. Continuous thoracic paravertebral block (TPVB) is also commonly performed at UPMC Presbyterian Shadyside . Over 2000 are performed annually for a wide variety of surgical procedures. Recently authors have suggested that a lumbar paravertebral block (LPVB) may represent an alternative approach to the lumbar plexus. Indeed the L2 paravertebral approach of the lumbar plexus has been described to provide adequate postoperative analgesia following hip arthroscopic surgery. However, to date, there is no prospective direct comparison between L2 Lumbar plexus approach and the posterior approach for postoperative analgesia after Total Hip Arthroplasty.

Being tested
L2 Paravertebral catheter nerve block, Continuous Lumbar plexus nerve block
Keywords
Postoperative Pain, Nerve block, Total Hip Arthroplasty, Postoperative analgesia, Lumbar Plexus Catheters, L2 Paravertebral Catheters
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • L2 Paravertebral catheter nerve blockProcedure or surgery

    A continuous L2 paravertebral catheter will be placed according to UPMC standard of care practices.

  • Continuous Lumbar plexus nerve blockProcedure or surgery

    A continuous unilateral lumbar plexus catheter will be placed according to UPMC standard of care practices.

Study groups in NCT01571492
Study groupRoleWhat they receive
L2 Paravertebral peripheral nerve blockExperimentalL2 paravertebral peripheral nerve block catheter will be placed.
Receives: Procedure: L2 Paravertebral catheter nerve block
Continuous Lumbar plexus peripheral nerve blockActive comparatorContinuous unilateral lumbar plexus peripheral nerve block catheter will be placed.
Receives: Procedure: Continuous Lumbar plexus nerve block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Opiate consumption

    Postoperative Opiate consumption will be recorded as Morphine IV mg equivalent, for the first 24 hours.

    Measured: 24 postoperatively

Secondary outcomes (5)
  1. NRS Pain Score (at rest)

    Pain scores at Rest will be recorded at 24 and 48 Hours

    Measured: 24 and 48 hours postoperatively

  2. NRS Pain Score during physical therapy

    Pain scores at Rest and During physical therapy will be recorded at 24 and 48 Hours

    Measured: 24 and 48 hours postoperatively

  3. TUG (Timed Up and Go)

    The timed get up and go test is a measurement of mobility. It includes a number of tasks such as standing from a seating position, walking, turning, stopping, and sitting down which are all important tasks needed for a person to be independently mobile.

    Measured: 24 hours postoperatively

  4. Straight Leg Raise(SLR)

    In supine position with the extremity being tested and contralateral flexed LE with foot flat on surface. Patient is instructed to lift extremity to level of contralateral knee. Inability to lift entire LE off of the surface to the level of the contralateral knee would be indicative of hip flexor weakness. If the patient is able to lift LE off of the surface, however the knee flexes/unable to maintain full knee extension, this is indicative of quad weakness.

    Measured: 24 hours postoperatively

  5. Long arc quad (LAQ)

    In sitting position at the edge of the bed or chair. Patient is asked to extend lower leg fully on side that is being tested. If able, this is indicative that quad function is intact. If unable to fully extend knee, would indicate quad weakness.

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2012 (estimated)
  2. Study startJun 2009
  3. Primary completionOct 2010
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01571492
Sponsor's protocol ID
PRO09010511
Status last verified
Jun 2017
First submitted
2 Apr 2012
Last updated
7 Jun 2017
Results posted
No
Data monitoring committee
No

Publications

  • Marino J, Russo J, Kenny M, Herenstein R, Livote E, Chelly JE. Continuous lumbar plexus block for postoperative pain control after total hip arthroplasty. A randomized controlled trial. J Bone Joint Surg Am. 2009 Jan;91(1):29-37. doi: 10.2106/JBJS.H.00079.

    PubMed 19122076
  • Lee EM, Murphy KP, Ben-David B. Postoperative analgesia for hip arthroscopy: combined L1 and L2 paravertebral blocks. J Clin Anesth. 2008 Sep;20(6):462-5. doi: 10.1016/j.jclinane.2008.04.012.

    PubMed 18929290
  • Capdevila X, Macaire P, Dadure C, Choquet O, Biboulet P, Ryckwaert Y, D'Athis F. Continuous psoas compartment block for postoperative analgesia after total hip arthroplasty: new landmarks, technical guidelines, and clinical evaluation. Anesth Analg. 2002 Jun;94(6):1606-13, table of contents. doi: 10.1097/00000539-200206000-00045.

    PubMed 12032037
  • Siddiqui ZI, Cepeda MS, Denman W, Schumann R, Carr DB. Continuous lumbar plexus block provides improved analgesia with fewer side effects compared with systemic opioids after hip arthroplasty: a randomized controlled trial. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):393-8. doi: 10.1016/j.rapm.2007.04.008.

    PubMed 17961837
  • Chudinov A, Berkenstadt H, Salai M, Cahana A, Perel A. Continuous psoas compartment block for anesthesia and perioperative analgesia in patients with hip fractures. Reg Anesth Pain Med. 1999 Nov-Dec;24(6):563-8. doi: 10.1016/s1098-7339(99)90050-0.

    PubMed 10588563
  • Kaloul I, Guay J, Cote C, Fallaha M. The posterior lumbar plexus (psoas compartment) block and the three-in-one femoral nerve block provide similar postoperative analgesia after total knee replacement. Can J Anaesth. 2004 Jan;51(1):45-51. doi: 10.1007/BF03018546.

    PubMed 14709460
  • Farny J, Drolet P, Girard M. Anatomy of the posterior approach to the lumbar plexus block. Can J Anaesth. 1994 Jun;41(6):480-5. doi: 10.1007/BF03011541.

    PubMed 8069987
  • Ilfeld BM, Ball ST, Gearen PF, Le LT, Mariano ER, Vandenborne K, Duncan PW, Sessler DI, Enneking FK, Shuster JJ, Theriaque DW, Meyer RS. Ambulatory continuous posterior lumbar plexus nerve blocks after hip arthroplasty: a dual-center, randomized, triple-masked, placebo-controlled trial. Anesthesiology. 2008 Sep;109(3):491-501. doi: 10.1097/ALN.0b013e318182a4a3.

    PubMed 18719448
  • Mannion S, O'Callaghan S, Walsh M, Murphy DB, Shorten GD. In with the new, out with the old? Comparison of two approaches for psoas compartment block. Anesth Analg. 2005 Jul;101(1):259-64, table of contents. doi: 10.1213/01.ANE.0000153866.38440.43.

    PubMed 15976242
  • Williams BA, Murinson BB. Diabetes mellitus and subclinical neuropathy: a call for new paths in peripheral nerve block research. Anesthesiology. 2008 Sep;109(3):361-2. doi: 10.1097/ALN.0b013e3181829f0d. No abstract available.

    PubMed 18719433
  • Zink W, Sinner B, Zausig Y, Graf BM. [Myotoxicity of local anaesthetics: experimental myth or clinical truth?]. Anaesthesist. 2007 Feb;56(2):118-27. doi: 10.1007/s00101-006-1121-5. German.

    PubMed 17235544

Questions about this trial

What is this clinical trial studying?

A study testing L2 Paravertebral catheter nerve block and Continuous Lumbar plexus nerve block in people with Total Hip Arthroplasty, run by University of Pittsburgh at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Opiate consumption (time frame: 24 postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01571492, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in